Taiwan FDA registration 7c4b0a904d8ae8937550c1bd85b28841

"Ruicheng" Bairka pneumoniae IgM screening reagent (unsterilized)

TW: “銳誠”拜爾卡肺炎黴漿菌IgM篩檢試劑(未滅菌)

Taiwan·Risk Class 1·Labsystems Diagnostics Oy·Registered May 31, 2012 – May 31, 2027Active

Registration details

Analysis ID: 7c4b0a904d8ae8937550c1bd85b28841
Customs Code: DHA04401177307

Company information

Manufacturer: Labsystems Diagnostics Oy
Manufacturer Country: Finland
Authorized Representative: RAFA INTERNATIONAL CORP.

Product details

Intended Use: Limited to the classification and grading management method of medical equipment, the first level identification range of "Mycoplasma serum reagent (C.3375)".
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.3375 黴漿菌屬血清試劑
Import Information: import

Dates and status

Registration Date: May 31, 2012
Expiry Date: May 31, 2027

About this record

Access comprehensive regulatory information for "Ruicheng" Bairka pneumoniae IgM screening reagent (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 7c4b0a904d8ae8937550c1bd85b28841 and manufactured by Labsystems Diagnostics Oy. The authorized representative in Taiwan is RAFA INTERNATIONAL CORP..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.